Abstract Introduction
Mesenchymal stem cells (MSCs) are a promising source of cells for regenerative therapies. Although they can be isolated easily from several tissues, cell expansion is limited since their properties are lost with successive passages. Hence, pluripotent derived MSCs (PD-MSCs) arise as a suitable alternative for MSC production. Nevertheless, at present, PD-MSC derivation protocols are either expensive or not suitable for clinical purposes.
In this work we present a therapy-grade, inexpensive and simple protocol to derive MSCs from pluripotent stem cells (PSCs) based on the use of platelet lysate (PL) as medium supplement.
We showed that the PD-MSCPL expressed multiple MSC markers, including CD90, CD73, CD105, CD166, and CD271, among others. These cells also show multilineage differentiation ability and immunomodulatory effects on pre-stimulated lymphocytes. Thorough characterization of these cells showed that a PD-MSCPL resembles an umbilical cord (UC) MSC and differs from a PSC in surface marker and extracellular matrix proteins and integrin expression. Moreover, the OCT-4 promoter is re-methylated with mesenchymal differentiation comparable with the methylation levels of UC-MSCs and fibroblasts. Lastly, the use of PL-supplemented medium generates significantly more MSCs than the use of fetal bovine serum.
This protocol can be used to generate a large amount of PD-MSCs with low cost and is compatible with clinical therapies.
Mesenchymal stem cells (MSC), sometimes also addressed as mesenchymal stromal cells, have been isolated from many different tissues and although some differences may be found according to their origin, most of them share their main features, including multipotent differentiation and immunomodulation [1]. Irrespective of the source of isolation, MSC have been found to be able to modulate the immune response. This feature has been extensively studied in vitro and in vivo in the past years, and MSC are currently assessed in clinical trials for their efficacy in the treatment of many immune-related diseases. Although MSC can be easily isolated from tissues such as bone marrow, umbilical cord or adipose tissue, it has been reported that these cells lose their properties rapidly with time, undergoing cellular senescence [2,3]. Moreover, it is possible that some therapies will require large and repeated doses of MSC. In the case that these therapies involve autologous MSC, there would be some limitations in the number of repeated procedures to obtain the cells. A limitless, economic source of MSC would therefore be a valid alternative when thinking in an autologous, off-the-shelf MSC therapy.
Platelet lysate (PL) is increasingly used instead of fetal bovine serum (FBS) as a medium supplement for growing MSC. PLs advantages have been described extensively, and include its biocompatibility with cell therapy, low cost, and easiness to produce [4,5]. PL contains a very significant amount of growth factors, released by the platelets after lysing in the freeze/thaw cycles [6-8]. These growth factors are involved in many relevant functions in stem cell biology, including basic fibroblast growth factor, insulin-like growth factor and transforming growth factor beta. Moreover, it has been demonstrated that growing MSC in PL-supplemented medium preserves the immunomodulatory ability of the cells [9]. PL supplement has been already used to grow MSC with success, and these cells are used in clinical trials involving MSC without presenting any adverse reaction [10].
Pluripotent stem cells (PSC) can differentiate into any type of adult stem cell. Interestingly, it has been reported that PSC can derive into cells that share many features with MSC isolated from adult tissues, and hence they have been called pluripotent-derived mesenchymal stem cells (PD-MSC) [11-13]. Many papers have described different protocols to derive PD-MSC, and some of them involve some complex manipulations or the use of cell separation methods [14-22]. Even though they are called mesenchymal cells, there are some disagreements between some papers regarding the identity of PD-MSC, and some authors consider that these cells are not related to MSC, based on their gene expression profile [23]. In any case, PD-MSC have been analyzed in many reports and they share many of the features of the adult MSC, including surface markers, multilineage differentiation and immunomodulation. Finally, there are some reports that have analyzed their therapeutic potential, and these cells have been shown to be very potent immunomodulators in animal models [24-27].
We have developed a method to derive PD-MSC using PL as a media supplement (PD-MSCPL). This protocol generates a very significant number of PD-MSC within 3 to 4weeks in a robust and consistent way. We believe that this method can be scaled up at low cost to produce a significant number of PD-MSCPL useful for clinical therapies.
H9 human embryonic stem cells (hES) were purchased from WiCell (Madison, Wisconsin, USA). Induced pluripotent stem cells (iPS) were generated in our laboratory (Maria Questa et al., unpublished observations) by standard techniques. Briefly, foreskin fibroblasts were reprogrammed by transfection with the STEMCCA lentivirus vector, generously obtained from Gustavo Mostovslasky [28]. Several clones have been characterized in our laboratory by demonstrating their pluripotent state and its ability to differentiate into cells from the three germinal layers and by the formation of teratomas. For this paper, we have used both clones FN2.1 and FH. PSC, either hES or iPS, are regularly grown in our laboratory over inactivated (by radiation) mouse embryonic fibroblasts, in Dulbeccos modified Eagles medium (DMEM)/F12 medium supplemented with 10% Knock-Out Serum Replacement, 8ng/ml basic fibroblast growth factor, and penicillinstreptomycin (all from Life Technologies, Carlsbad, California, USA), under standard culture conditions (37C with a 5% carbon dioxide humidified atmosphere). Medium is changed daily. Human umbilical cord mesenchymal stem cells (UC-MSC) were isolated from Wharton jelly tissues. Derivation of UC-MSC was done with due consent from the donors parents. Small pieces of the umbilical cord, excluding the major vessels, were layered onto plastic and cultured in alpha modified Eagles medium supplemented with 10% PL and penicillinstreptomycin. Fibroblasts were obtained from the foreskin of a patient undergoing scheduled surgery, with informed consent from the parents. These cells are grown in DMEM supplemented with 10% FBS and antibiotics. All isolations of primary cells were approved by FLENI Ethical Committee after reviewing the research protocol.
View original post here:
Stem Cell Research & Therapy | Full text | A therapy-grade ...
- More Stem Cells Extracted For Later Use For My MS - March 14th, 2011 [March 14th, 2011]
- Stem Cell Institute Panama City Panama - April 1st, 2011 [April 1st, 2011]
- Cells That Heal Us From Cradle To Grave: A Quantum Leap in Medical Science - April 8th, 2011 [April 8th, 2011]
- Macular Degeneration Improved With Stem Cells - April 8th, 2011 [April 8th, 2011]
- Stem Cell Therapy for Kidney Failure - April 15th, 2011 [April 15th, 2011]
- SIRA: Could Stem Cell Therapy Renew Your Body Cells? - April 22nd, 2011 [April 22nd, 2011]
- Stem Cell Therapy for Autism - May 20th, 2011 [May 20th, 2011]
- Stem Cell Therapy for Critical Limb Ischemia - May 21st, 2011 [May 21st, 2011]
- STEM CELLS FOR MACULAR DEGENERATION Sam Smith's story.wmv - May 21st, 2011 [May 21st, 2011]
- Stem Cell Therapy Success - May 21st, 2011 [May 21st, 2011]
- Doctors Use Stem Cells to Grow New Windpipes - May 21st, 2011 [May 21st, 2011]
- Dog Undergoes Stem Cell Therapy - May 23rd, 2011 [May 23rd, 2011]
- Stem Cell Therapy for Multiple Sclerosis - May 23rd, 2011 [May 23rd, 2011]
- Dogs now getting stem cell therapy - May 24th, 2011 [May 24th, 2011]
- Stem Cell Therapy for Rheumatoid Arthritis - May 30th, 2011 [May 30th, 2011]
- Stem Cell Therapy for Type II Diabetes - May 31st, 2011 [May 31st, 2011]
- Stem Cell Therapy for Cerebral Palsy - May 31st, 2011 [May 31st, 2011]
- Visions Episode 92: Stem Cells Discovery - May 31st, 2011 [May 31st, 2011]
- Stem Cell Therapy For Alzheimer's/Dementia - June 1st, 2011 [June 1st, 2011]
- Stem Cell Patient Richard H. MS Treatment - June 10th, 2011 [June 10th, 2011]
- Stem Cell Therapy Injections - June 12th, 2011 [June 12th, 2011]
- Stem Cells Used to Grow Windpipes - June 20th, 2011 [June 20th, 2011]
- Stem Cell Therapy for Stroke - Gary Steinberg, Stanford University - June 21st, 2011 [June 21st, 2011]
- Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Approach - June 23rd, 2011 [June 23rd, 2011]
- Stem Cell Therapy Cream: Less Wrinkles In 30 Days or Less Anti-Wrinkle Cream That Works - June 26th, 2011 [June 26th, 2011]
- Stem Cell Therapy for Spinal Cord Injury - Injured Airline Pilot Flies Again - June 27th, 2011 [June 27th, 2011]
- Clinical Advances in Adult Stem Cell Therapy: Dr. Jorge Paz - June 27th, 2011 [June 27th, 2011]
- Stem Cell Injection Treatment - Stem Cell Therapy - June 27th, 2011 [June 27th, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 27th, 2011 [June 27th, 2011]
- Documentary: Stem Cell Therapy for Muscular Dystrophy - Ryan Benton's Story - June 30th, 2011 [June 30th, 2011]
- Stem Cell Therapy--Hillcrest Animal Hospital - July 14th, 2011 [July 14th, 2011]
- WAVE3 News Adipose Stem Cell Therapy - July 20th, 2011 [July 20th, 2011]
- Lou Gehrig's Disease (ALS): Stem Cell Therapy - A Patient's Perspective - July 23rd, 2011 [July 23rd, 2011]
- University of Melbourne announce Stem Cells Discovery - July 28th, 2011 [July 28th, 2011]
- Stem Cell Therapy (Regenerative Medicine) in New Jersey - August 9th, 2011 [August 9th, 2011]
- Spinal Cord Injury - Stem Cell Therapy - August 9th, 2011 [August 9th, 2011]
- Dr. Craig Saunders Adult Stem Cell Therapy - August 9th, 2011 [August 9th, 2011]
- Embryonic stem cell therapy in China (www.esctherapy.com) - August 13th, 2011 [August 13th, 2011]
- Mesenchymal stem cells and marrow stromal cells - August 15th, 2011 [August 15th, 2011]
- Mesenchymal Stem Cells in Regenerative Medicine: Of Hopes and Challenges - August 15th, 2011 [August 15th, 2011]
- Cardiomyogenic differentiation of Mesenchymal Stem cells (KUM2/9-15c) - August 15th, 2011 [August 15th, 2011]
- SENS4 - Engineered Mesenchymal Stem Cells - The Road to Skeletal Tissue Regeneration (1/3) - August 15th, 2011 [August 15th, 2011]
- Mesenchymal stem cells and marrow stromal cells---2nd--- - August 15th, 2011 [August 15th, 2011]
- Cadiomyogenesis of human mesenchymal stem cells - August 15th, 2011 [August 15th, 2011]
- Mesenchymal Stem Cells Transplantation In Heart.wmv - August 15th, 2011 [August 15th, 2011]
- Ying Liu discusses IPS cell therapy for ALS - August 15th, 2011 [August 15th, 2011]
- Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. - Miami, FL - August 16th, 2011 [August 16th, 2011]
- From Surgical Repair to Stem Cell Repair: A Surgeon's Journey by Leonard Smith MD, FACS - August 16th, 2011 [August 16th, 2011]
- Bone Marrow Aspiration - Stem Cell Therapy - August 16th, 2011 [August 16th, 2011]
- Non-controversial Stem Cells: Rationale for Clinical Use - Dr. Neil Riordan - August 16th, 2011 [August 16th, 2011]
- TEDxSingapore - Susan Lim - Hype and hope of stem cell research - August 16th, 2011 [August 16th, 2011]
- Cryo-Lip Instruction Video.VOB.flv - August 16th, 2011 [August 16th, 2011]
- Stem Cells Repair Damaged Heart [7-07-2011] - August 16th, 2011 [August 16th, 2011]
- Andalusian Stem Cell Bank - August 16th, 2011 [August 16th, 2011]
- Adult Stem Cell Therapy Clinical Advances - Dr. Jorge Paz in San Diego, CA March 2011 - August 16th, 2011 [August 16th, 2011]
- Mesenchymal Stem Cells Drive New MS Study/Treatment - August 26th, 2011 [August 26th, 2011]
- Sims 2 Mafia Story Part 7 - Farewell, Godfather/Stem Cell Medicine - August 28th, 2011 [August 28th, 2011]
- STEM CELLS - Mesenchymal Stem Cells (Balzitt).flv - August 30th, 2011 [August 30th, 2011]
- Regenerative Medicine With Stem Cell Therapy Injections at an Arizona pain clinic (602) 507-6550 - September 3rd, 2011 [September 3rd, 2011]
- Stem Cell Research: Huntington's Disease - September 5th, 2011 [September 5th, 2011]
- Autism Stem Cell Trip - September 6th, 2011 [September 6th, 2011]
- Before/After Stem Cell for COPD: From Unable to Walk, to Dancing at My Daughter's Wedding - September 6th, 2011 [September 6th, 2011]
- Regenerative Medicine with Placenta Extracts and Stem Cell Therapies - Dr. Janethy Balakrishnan - September 6th, 2011 [September 6th, 2011]
- Stem Cells - September 6th, 2011 [September 6th, 2011]
- The Politics and Promise of Stem Cell Research - September 6th, 2011 [September 6th, 2011]
- Stem cell therapy in Guatemala - (closer than China) - September 7th, 2011 [September 7th, 2011]
- Stem Cell Therapy for Cerebral Palsy - Holly Catalano - September 9th, 2011 [September 9th, 2011]
- Clinical Advances in Adult Stem Cell Therapy - Dr. Jorge Paz Rodriguez (Miami) - September 9th, 2011 [September 9th, 2011]
- CryoLip Stem Cell Preservation - September 20th, 2011 [September 20th, 2011]
- Dr. Gonzalez tells his story of Stem Cell Treatment and Stem Cell Therapy - September 23rd, 2011 [September 23rd, 2011]
- A Three Minute Cell Passage - September 23rd, 2011 [September 23rd, 2011]
- Bone Marrow - Stem Cell Prolotherapy - September 23rd, 2011 [September 23rd, 2011]
- Stem Cell Therapy- Interview with Indian Surgeon - September 23rd, 2011 [September 23rd, 2011]
- Cryo-Lip.f4v - September 23rd, 2011 [September 23rd, 2011]
- CryoCord Corporate Video (2 Mins) - September 23rd, 2011 [September 23rd, 2011]
- SENS4 - Engineered Mesenchymal Stem Cells - The Road to Skeletal Tissue Regeneration (3/3) - September 23rd, 2011 [September 23rd, 2011]
- What are stem cells? - September 24th, 2011 [September 24th, 2011]
- Dental stem cell bank in Hyderabad - September 24th, 2011 [September 24th, 2011]
- Stem Cell Therapeutics: Tissue Regeneration - Christopher J. Centeno, MD - September 25th, 2011 [September 25th, 2011]
- Stem Cell Types and Sources - September 25th, 2011 [September 25th, 2011]